| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $184K | -29.0% |
| R&D Expense | $2.5M | +74.9% |
| SG&A Expense | $226K | -68.5% |
| Operating Income | -$2.6M | -35.2% |
| Interest Expense | $10K | +40.6% |
| Pre-tax Income | -$2.6M | -39.3% |
| Net Income | -$2.6M | -39.3% |
| EPS (Basic) | -$0.64 | -16.4% |
| EPS (Diluted) | -$0.64 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | +262.3% |
| Short-term Investments | $301K | +0.0% |
| Accounts Receivable | $114K | — |
| Current Assets | $5.8M | +220.7% |
| Total Assets | $6.0M | +195.6% |
| Current Liabilities | $1.2M | +245.9% |
| Total Liabilities | $1.3M | +116.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | -85.1% |
| Investing Cash Flow | $301K | +200.0% |
| Financing Cash Flow | $5.2M | +149.8% |
| -16.4% |
| Stockholders' Equity |
| $4.7M |
| +228.4% |